Raphael Pharmaceutical Inc.
RAPH
Rank in Stocks
#24797
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating... Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
Share Price
$1.51
Last synced: 2026-11-06
Market Cap
$30.47M
Change (1 day)
0.00%
Change (1 year)
51.00%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Raphael Pharmaceutical Inc. (RAPH)
Category
Healthcare
EPS for Raphael Pharmaceutical Inc. (RAPH)
EPS as of June 2026 TTM: $-0.05
According to Raphael Pharmaceutical Inc.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.07, an increase over its 2024 EPS of $-0.08.
EPS history for Raphael Pharmaceutical Inc. from 2021 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | -29.71% |
| 2025 | $-0.07 | -19.56% |
| 2024 | $-0.08 | 1.12% |
| 2023 | $-0.08 | -65.04% |
| 2022 | $-0.23 | 130.00% |
| 2021 | $-0.10 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -13,314.23% |
DE
|
|
| $6.08 | -12,452.85% |
DE
|
|
| $1.55 | -3,251.63% |
JP
|
|
| $3.66 | -7,539.02% |
CH
|
|
| $0.45 | -1,014.63% |
IL
|
Questions about Raphael Pharmaceutical Inc.'s earnings per share (EPS)
What is Raphael Pharmaceutical Inc.'s earnings per share (EPS)?
Raphael Pharmaceutical Inc.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Jun 2026.
What was Raphael Pharmaceutical Inc.'s earnings per share (EPS) in 2025?
In 2025, Raphael Pharmaceutical Inc.'s earnings per share (EPS) was $-0.07, compared with $-0.08 in 2024.
How has Raphael Pharmaceutical Inc.'s earnings per share (EPS) changed since 2021?
From 2021 to 2025, Raphael Pharmaceutical Inc.'s earnings per share (EPS) was highest in 2025 ($-0.07) and lowest in 2022 ($-0.23).
How does Raphael Pharmaceutical Inc.'s earnings per share (EPS) compare with similar companies?
Raphael Pharmaceutical Inc.'s earnings per share (EPS) ($-0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.